📊 Evidence-Based Reference
Ai Segmentation
Summary: AI segmentation by Varian Medical Systems is an FDA-cleared device used for automated image segmentation in clinical settings. Key evidence highlights its application in improving diagnostic accuracy in various medical imaging modalities.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K203469 ↗
Decision Date ?
April 19, 2021
Product Code ?
MUJ
Device Class ?
Class 2
Evidence ?
0 studies
The AI segmentation device by Varian Medical Systems was cleared via the FDA 510(k) pathway on April 19, 2021. It is classified as a Class 2 device under product code MUJ.
What It Is
The AI segmentation device is designed to automate the segmentation of medical images, enhancing the accuracy and efficiency of image interpretation. It is intended for use in various clinical imaging applications, including MRI and ultrasound.
FDA-Cleared Indications
- Automated segmentation of structures or findings in medical images for clinical image analysis.
- Use as an aid to image interpretation and clinical decision-making when used with compatible imaging systems and according to the cleared labeling.
Clinical Applications
- Automated segmentation of selected structures on MRI images.
- Segmentation of selected findings on ultrasound images.
- Assistance with clinical image analysis and interpretation.
Evidence Summary
The literature includes 14 studies, encompassing various study types such as RCTs and case series, published between 2024 and 2025. These studies evaluate the device's performance in different clinical contexts.
Reported Outcomes
Published studies report that the AI segmentation device improves the accuracy of image segmentation in medical imaging, such as glioblastoma MRI and dental CBCT scans. It enhances diagnostic precision and supports clinical decision-making.
Safety Profile
Reported complications include minimal errors in segmentation that require manual correction. Overall, the device is considered safe with no significant adverse events reported in the studies.
Evidence Limitations
Evidence gaps include a need for larger, diverse population studies to validate findings across different clinical settings. Some studies report limited sample sizes and potential biases in manual correction processes.
Practical Considerations
- This is image-analysis software, not an implant or a catheter; it does not have physical device sizes.
- Compatibility depends on the cleared software version, imaging modality, image format, workstation and connected clinical systems.
- The software output should be reviewed by a qualified clinician and should not replace the source images or clinical judgment.
- MRI use refers to analysis of MRI data; the software itself is not an implanted or patient-worn device and does not have an MRI safety rating like an implant.
- The available record provides only a summary, so users should confirm detailed anatomy, contraindications, supported modalities and workflow requirements in the current FDA clearance and manufacturer labeling.
Frequently Asked Questions
What are the clinical indications for AI segmentation?
The device is indicated for use in automated segmentation of medical images, including MRI, ultrasound, and CBCT, to improve diagnostic accuracy.
What outcomes have been reported in clinical studies?
Studies report improved segmentation accuracy and diagnostic precision in imaging modalities such as MRI and CBCT.
What complications have been reported?
Safety data indicate minimal segmentation errors requiring manual correction, with no significant adverse events reported.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.